• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Danimer Scientific Inc.

    11/15/24 5:00:02 PM ET
    $DNMR
    Major Chemicals
    Industrials
    Get the next $DNMR alert in real time by email
    NT 10-Q 1 nt_10-q_-_3q_2024.htm NT 10-Q NT 10-Q

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 12b-25

    NOTIFICATION OF LATE FILING

     

    (Check one):

    ☐
    Form 10-K
    ☐
    Form 20-F
    ☐
    Form 11-K

     

     

    ☒ Form 10-Q

    ☐
    Form 10-D
    ☐
    Form N-CEN
    ☐
    Form N-CSR

     

    For Period Ended: September 30, 2024

     

     

    ☐
    Transition Report on Form 10-K
    ☐
    Transition Report on Form 20-F
    ☐
    Transition Report on Form 11-K
    ☐
    Transition Report on Form 10-Q

    For the Transition Period Ended:

    Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

    Not Applicable

    PART I — REGISTRANT INFORMATION

    Danimer Scientific, Inc.

    Full Name of Registrant

    140 Industrial Boulevard

    Address of Principal Executive Office (Street and Number)

    Bainbridge, GA 39817

    City, State and Zip Code


     

    PART II — RULES 12b-25(b) AND (c)

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

    (a)

    The reason described in reasonable detail in Part III of this Form could not be eliminated without unreasonable effort or expense;

     

     

    [X]

    (b)

    The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

     

    (c)

    The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

    PART III — NARRATIVE

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

    As previously disclosed, the Registrant has undertaken an ongoing comprehensive program of capital conservation and expense reduction, and is also analyzing a variety of transactions to provide additional sources of liquidity. These efforts and discussions have involved significant time by members of the Registrant's management and its Board of Directors. As a result of the increased workload associated with these efforts, including their impact on procedures related to finalizing its quarterly filing, the Registrant is unable to file its Form 10-Q for the quarterly period ended September 30, 2024 within the prescribed time period without unreasonable effort or expense.

    The Registrant intends to file this Form 10-Q no later than the prescribed due date provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended. The Registrant anticipates that this Form 10-Q will disclose that substantial doubt exists about the Registrant's ability to continue as a going concern for twelve months following the expected issuance date of the Form 10-Q.

    PART IV — OTHER INFORMATION

    (1)
    Name and telephone number of person to contact in regard to this notification

    Stephen A. Martin 812 618-6996

    (Name) (Area Code) (Telephone Number)

    (2)
    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No
    (3)
    Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

    ☐ Yes ☒No

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     


     

    Danimer Scientific, Inc.

    (Name of Registrant as Specified in Charter)

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

    Date November 15, 2024 By /s/ Stephen A. Martin

    Chief Legal Officer and Corporate Secretary

     

     


    Get the next $DNMR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DNMR

    DatePrice TargetRatingAnalyst
    11/21/2024$40.00 → $5.50Hold
    TD Cowen
    11/20/2024$40.00 → $4.00Neutral → Underweight
    Piper Sandler
    8/13/2024$2.00 → $1.00Buy → Hold
    TD Cowen
    5/22/2024$1.30 → $0.80Buy → Hold
    Jefferies
    4/9/2024$3.50 → $1.25Overweight → Neutral
    Piper Sandler
    10/12/2022$4.50Overweight
    Piper Sandler
    9/23/2021$21.00Outperform
    Cowen
    More analyst ratings

    $DNMR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace

    –Dividend warrants continue to trade on OTCQX marketplace under "DNMRW"– Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that it received notice the New York Stock Exchange ("NYSE") suspended trading of its common stock on the NYSE effective immediately and started the process to delist its common stock from the NYSE. The start of the delisting process follows the NYSE's determination under Rule 802.01B of the NYSE Listed Company Manual that the Company did not meet the continued listing standard that requires listed companies to maintain a

    12/31/24 8:00:00 AM ET
    $DNMR
    Major Chemicals
    Industrials

    Danimer Scientific Takes Action to Strengthen Capital Structure

    Announces Issuance of $11,250,000 Super Senior Secured Promissory Note Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that the Company issued a super senior secured promissory note (the "Secured Loan") in an aggregate principal amount of $11,250,000 to certain lenders under its existing term loan financing agreement, as well as certain additional lenders. The Secured Loan provides for $11,250,000 gross proceeds, less fees and expenses. The Secured Loan has a two-year maturity and accrues interest at 15.0% per annum, which interest is payab

    12/17/24 4:15:00 PM ET
    $DNMR
    Major Chemicals
    Industrials

    TerraNova Capital Equities announces three transactions totaling $45 Million

    NEW YORK, Nov. 20, 2024 /PRNewswire/ -- TerraNova Capital Equities, inc. (TerraNova), a leading financial advisory firm, is pleased to announce that its Structure Finance Group acted as sole advisor on three recent transactions: TerraNova Structured Finance Group acted as the sole advisor to Danimer Scientific, Inc. (NYSE:DNMR) on a $20 Million revolving credit facility. TerraNova is pleased to announce its role as the exclusive advisor to Danimer Scientific in securing a strategic ABL agreement with Mountain Ridge Capital.  This $20 million facility, collateralized by the Com

    11/20/24 10:30:00 AM ET
    $DNMR
    $INUV
    Major Chemicals
    Industrials
    Advertising
    Consumer Discretionary

    $DNMR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Hajost Michael A converted options into 859 shares and covered exercise/tax liability with 301 shares, increasing direct ownership by 31% to 2,334 units (SEC Form 4)

    4 - Danimer Scientific, Inc. (0001779020) (Issuer)

    2/10/25 4:30:05 PM ET
    $DNMR
    Major Chemicals
    Industrials

    Director Moody David Jesse converted options into 646 shares (SEC Form 4)

    4 - Danimer Scientific, Inc. (0001779020) (Issuer)

    1/21/25 4:30:10 PM ET
    $DNMR
    Major Chemicals
    Industrials

    SEC Form 4 filed by Director Croskrey Stephen

    4 - Danimer Scientific, Inc. (0001779020) (Issuer)

    1/3/25 4:05:07 PM ET
    $DNMR
    Major Chemicals
    Industrials

    $DNMR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Hendrix Richard J bought $93,395 worth of shares (100,000 units at $0.93) (SEC Form 4)

    4 - Danimer Scientific, Inc. (0001779020) (Issuer)

    11/28/23 5:35:32 PM ET
    $DNMR
    Major Chemicals
    Industrials

    $DNMR
    SEC Filings

    View All

    Danimer Scientific Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - Danimer Scientific, Inc. (0001779020) (Filer)

    3/18/25 5:00:42 PM ET
    $DNMR
    Major Chemicals
    Industrials

    Danimer Scientific Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Danimer Scientific, Inc. (0001779020) (Filer)

    2/28/25 5:00:09 PM ET
    $DNMR
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Danimer Scientific Inc.

    SCHEDULE 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)

    2/14/25 5:41:32 PM ET
    $DNMR
    Major Chemicals
    Industrials

    $DNMR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Danimer Scientific with a new price target

    TD Cowen reiterated coverage of Danimer Scientific with a rating of Hold and set a new price target of $5.50 from $40.00 previously

    11/21/24 8:09:13 AM ET
    $DNMR
    Major Chemicals
    Industrials

    Danimer Scientific downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Danimer Scientific from Neutral to Underweight and set a new price target of $4.00 from $40.00 previously

    11/20/24 9:49:17 AM ET
    $DNMR
    Major Chemicals
    Industrials

    Danimer Scientific downgraded by TD Cowen with a new price target

    TD Cowen downgraded Danimer Scientific from Buy to Hold and set a new price target of $1.00 from $2.00 previously

    8/13/24 7:29:01 AM ET
    $DNMR
    Major Chemicals
    Industrials

    $DNMR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Danimer Scientific Inc.

    SC 13G - Danimer Scientific, Inc. (0001779020) (Subject)

    11/14/24 3:28:09 PM ET
    $DNMR
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Danimer Scientific Inc.

    SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)

    7/8/24 4:36:39 PM ET
    $DNMR
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Danimer Scientific Inc. (Amendment)

    SC 13G/A - Danimer Scientific, Inc. (0001779020) (Subject)

    1/29/24 5:25:54 PM ET
    $DNMR
    Major Chemicals
    Industrials

    $DNMR
    Leadership Updates

    Live Leadership Updates

    View All

    Danimer Scientific Announces New Directors

    Dr. David Moody and Richard Altice to Join the Danimer Board Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the production of biodegradable materials, is pleased to announce that Dr. David Moody and Mr. Richard Altice have been appointed as members of Danimer's Board of Directors. Dr. Moody's appointment is effective immediately, and Mr. Altice's appointment is effective as of April 15, 2024. Dr. David J. Moody currently is a member of the Board of Directors of Jadex Inc., a US-based manufacturing and material science company utilizing innovation and technology to develop sustainable products that serve the me

    1/18/24 4:30:00 PM ET
    $DNMR
    Major Chemicals
    Industrials

    Danimer Scientific Appoints Stephen Martin as Chief Legal Officer and Corporate Secretary

    Martin, a Duke University graduate and former Air Force officer, brings experience managing the legal affairs of publicly traded companies Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it has appointed Stephen Martin as Chief Legal Officer and Corporate Secretary. In this role, Martin will manage a wide range of legal matters across the company as Danimer continues to expand its manufacturing capacity to meet demand in the fast-growing bioplastics market. Martin joins Danimer from Kaman Distribution Group, a leading national distributor o

    9/20/22 8:30:00 AM ET
    $DNMR
    Major Chemicals
    Industrials

    Danimer Scientific Appoints Anthony Austin as Chief Human Resource Officer

    Austin brings more than 30 years of human resources leadership experience with PepsiCo, Delta Air Lines, Winn-Dixie and others Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it has appointed Anthony Austin as Chief Human Resource Officer. In this role, Austin will focus on building best-in-class HR processes to strategically support the Company's growth as it continues to expand its manufacturing capacity. Austin joins Danimer from Bedrock Manufacturing Co., the parent company of Shinola, a luxury watch, leather and jewelry manufacturer an

    4/20/22 8:00:00 AM ET
    $DNMR
    Major Chemicals
    Industrials

    $DNMR
    Financials

    Live finance-specific insights

    View All

    Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace

    –Dividend warrants continue to trade on OTCQX marketplace under "DNMRW"– Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that it received notice the New York Stock Exchange ("NYSE") suspended trading of its common stock on the NYSE effective immediately and started the process to delist its common stock from the NYSE. The start of the delisting process follows the NYSE's determination under Rule 802.01B of the NYSE Listed Company Manual that the Company did not meet the continued listing standard that requires listed companies to maintain a

    12/31/24 8:00:00 AM ET
    $DNMR
    Major Chemicals
    Industrials

    Danimer Scientific Announces Third Quarter 2024 Results

    --Additional Resin Orders and Deliveries Continue to Support 20-Million Pound Cutlery Award –- -- 100% Compostable Skittles® Bag Made with Nodax® PHA Featured at NFL Game -- Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its third quarter ended September 30, 2024. Richard N. Altice, Interim Chief Executive Officer of Danimer, commented, "We completed the third quarter in line with our expectations considering the temporary impact of Starbucks' reapportionment of their Nodax-based straw business between our convert

    11/19/24 8:30:00 AM ET
    $DNMR
    Major Chemicals
    Industrials

    Danimer Scientific Announces Release Date for Third Quarter 2024 Results

    Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its third quarter 2024 financial results before the market opens on Tuesday, November 19, 2024. A webcast and conference call will be held that same day at 10:00 a.m. Eastern Time to review the Company's third quarter results. The webcast of the conference will be accessible on the Investor Relations section of the Company's website at https://ir.danimerscientific.com. For those unable to access the webcast, the conference call will be accessible domestically o

    11/14/24 9:00:00 AM ET
    $DNMR
    Major Chemicals
    Industrials